Literature DB >> 17118449

Internalization and molecular interactions of human CD21 receptor.

Jacques Tessier1, Armelle Cuvillier, Florence Glaudet, Ahmed Amine Khamlichi.   

Abstract

The human CD21 is a receptor for cleavage fragments of the third complement component and for Epstein-Barr virus. Previous mutational studies showed that the cytoplasmic domain of CD21 is absolutely required for internalization of either ligand. With the exception of CD19, CD81, Leu-13 and CD35 that can form a complex with CD21 at the cell surface, no other partner that interacts with the hCD21 transmembrane or the cytoplasmic domain was identified. We investigated the internalization capacity of hCD21 tail mutants in the absence of B cell receptor cross-linking by using stable murine B cell transfectants. We provide evidence that at least two internalization motifs are activated when hCD21 binds a monoclonal antibody. In order to identify the cellular proteins that interact with the hCD21 transmembrane and cytoplasmic domains, we combined a mutational mapping with a two-hybrid system approach both in yeast and in mammalian cells. We identified four novel partners that are involved in intracellular trafficking, sorting or cytoskeleton remodeling and we mapped the hCD21 transmembrane and tail subdomains they interact with. We discuss the potential physiological significance of these findings in the context of hCD21 internalization and intracellular trafficking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118449     DOI: 10.1016/j.molimm.2006.10.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Authors:  Mohamed S Arredouani; Manoj K Bhasin; David R Sage; Laura K Dunn; Michael B Gill; Deep Agnani; Towia A Libermann; Joyce D Fingeroth
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

3.  A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.

Authors:  Liudmila Kulik; Finnegan B Hewitt; Van C Willis; Rosa Rodriguez; Stephen Tomlinson; V Michael Holers
Journal:  Mol Immunol       Date:  2015-02       Impact factor: 4.407

4.  Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.

Authors:  Liudmila Kulik; Jennifer Laskowski; Brandon Renner; Rachel Woolaver; Lian Zhang; Taras Lyubchenko; Zhiying You; Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

5.  Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

Authors:  Liudmila Kulik; Sherry D Fleming; Chantal Moratz; Jason W Reuter; Aleksey Novikov; Kuan Chen; Kathy A Andrews; Adam Markaryan; Richard J Quigg; Gregg J Silverman; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

Authors:  Claire Shannon-Lowe; Martin Rowe
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

7.  High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.

Authors:  Gladys S Ingle; Pamela Chan; J Michael Elliott; Wesley S Chang; Hartmut Koeppen; Jean-Philippe Stephan; Suzie J Scales
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

8.  CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease.

Authors:  Erin M Wilfong; Katherine N Vowell; Kaitlyn E Bunn; Elise Rizzi; Narender Annapureddy; Rosemarie B Dudenhofer; April Barnado; Rachel H Bonami; Joyce E Johnson; Leslie J Crofford; Peggy L Kendall
Journal:  Clin Exp Med       Date:  2021-08-10       Impact factor: 5.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.